⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Elamipretide (SS-31)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-11-11 — The Short Peptide Elamipretide Delays Ovarian Aging in Mice: [animal-model] A news report describes improved oocyte quality and delayed ovarian aging in elamipretide-treated mice, alongside improved quality in human oocytes treated in vitro; these preclinical findings do not establish fertility benefits or delayed ovarian aging in women. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
The Short Peptide Elamipretide Delays Ovarian Aging in Mice
11-nov-2026
novelty 3
per-area 3
strengthens